Share (%) of capital invested by sector and deal size 15 d e t s e v n i l 10 a t i p a c l a t o t f o ) 5 % ( e r a h S 0 … L s y h n e y t s e s g ty R e h ts g k e g t o r c n e r c n i c c n n / M cl r al ti a n e n a ti ti r V r e n li ri y / i e C e u / e e e a m o w s e T o D it I h n H t l rr e r d i k c R m m o il A e E r ta u r D r g r e A R y T & b V o i c u a o a S m H a a c p ig o s & H L M r o P ta d in ri s D t a s & e c a oo a t n p e ic & b - D F t c a y M t in s y E s e r r o a e C u l T C on b h al S E & b o C S n r R y i a l a C p h p c Su k Notes: oc l Data is as of 30 B September 2023. Excludes the following: biotech, secondary transac- tions, debt, lending capital, and grants. Sources: Powered by We’re in the midst of a generational shift in healthcare, where technology and AI are set to dramatically speed up and change the way we practise medicine. Hjalmar Nilsonne Co-Founder & CEO, Neko Health For Europe to compete on the global stage and build business- es as valuable as the US and China, we must excel not only in software but in pioneering hardware too. If we in Europe want to shape the future of healthcare, we must have companies in our region who are creating that future. Our ambition must match our capability to innovate and integrate, to truly in昀氀uence the healthcare of tomorrow. | 136